A phase 1, randomized double-blind, placebo controlled trial to evaluate safety and efficacy of epigallocatechin-3-gallate and cognitive training in adults with Fragile X syndrome
Rafael de la Torre, Susana de Sola, Magí Farré, Laura Xicota, Aida Cuenca-Royo, Joan Rodriguez, Alba León, Klaus Langohr, María Gomis-González, Gimena Hernandez, Susanna Esteba, Laura del Hoyo, Júdit Sánchez-Gutiérrez, Maria José Cortés, Andrés Ozaita, Josep María Espadaler, Ramón Novell, Rafael Martínez-Leal, Montserrat Milá, Mara DierssenAlessandro Principe, Gonzalo Sánchez, Júdit Sánchez-Gutiérrez, Laia Roca, Rafasel de la Torre, Montserrat Fitó, Ovideo Banea, Maria José Cortés, Montserrat Milà, Rafael Maldonado, Arnau Busquets-Garcia, Andrés Ozaita, María Gomis-González
Dive into the research topics of 'A phase 1, randomized double-blind, placebo controlled trial to evaluate safety and efficacy of epigallocatechin-3-gallate and cognitive training in adults with Fragile X syndrome'. Together they form a unique fingerprint.